Nishimura MI - Search Results

1

Combination immunotherapies implementing adoptive T-cell transfer for advanced-stage melanoma.

Foley KC, Nishimura MI, Moore TV. Foley KC, et al. Among authors: nishimura mi. Melanoma Res. 2018 Jun;28(3):171-184. doi: 10.1097/CMR.0000000000000436. Melanoma Res. 2018. PMID: 29521881 Free PMC article. Review.

2

Adoptive transfer of cloned melanoma-reactive T lymphocytes for the treatment of patients with metastatic melanoma.

Dudley ME, Wunderlich J, Nishimura MI, Yu D, Yang JC, Topalian SL, Schwartzentruber DJ, Hwu P, Marincola FM, Sherry R, Leitman SF, Rosenberg SA. Dudley ME, et al. Among authors: nishimura mi. J Immunother. 2001 Jul-Aug;24(4):363-73. doi: 10.1097/00002371-200107000-00012. J Immunother. 2001. PMID: 11565838 Clinical Trial.

3

Simultaneous generation of CD8+ and CD4+ melanoma-reactive T cells by retroviral-mediated transfer of a single T-cell receptor.

Roszkowski JJ, Lyons GE, Kast WM, Yee C, Van Besien K, Nishimura MI. Roszkowski JJ, et al. Among authors: nishimura mi. Cancer Res. 2005 Feb 15;65(4):1570-6. doi: 10.1158/0008-5472.CAN-04-2076. Cancer Res. 2005. PMID: 15735047

4

A new murine tumor model for studying HLA-A2-restricted anti-tumor immunity.

Kaplan BL, Moore TV, Schreiber K, Callender GG, Schreiber H, Nishimura MI. Kaplan BL, et al. Among authors: nishimura mi. Cancer Lett. 2005 Jun 16;224(1):153-66. doi: 10.1016/j.canlet.2004.11.035. Epub 2004 Dec 25. Cancer Lett. 2005. PMID: 15911111

5

Antigen recognition and T-cell biology.

Nishimura MI, Roszkowski JJ, Moore TV, Brasic N, McKee MD, Clay TM. Nishimura MI, et al. Cancer Treat Res. 2005;123:37-59. doi: 10.1007/0-387-27545-2_2. Cancer Treat Res. 2005. PMID: 16211865 Review.

6

Identification of a hepatitis C virus-reactive T cell receptor that does not require CD8 for target cell recognition.

Callender GG, Rosen HR, Roszkowski JJ, Lyons GE, Li M, Moore T, Brasic N, McKee MD, Nishimura MI. Callender GG, et al. Among authors: nishimura mi. Hepatology. 2006 May;43(5):973-81. doi: 10.1002/hep.21157. Hepatology. 2006. PMID: 16628627

7

Influence of human CD8 on antigen recognition by T-cell receptor-transduced cells.

Lyons GE, Moore T, Brasic N, Li M, Roszkowski JJ, Nishimura MI. Lyons GE, et al. Among authors: nishimura mi. Cancer Res. 2006 Dec 1;66(23):11455-61. doi: 10.1158/0008-5472.CAN-06-2379. Cancer Res. 2006. PMID: 17145893

8

Relationship between CD8-dependent antigen recognition, T cell functional avidity, and tumor cell recognition.

Moore TV, Lyons GE, Brasic N, Roszkowski JJ, Voelkl S, Mackensen A, Kast WM, Le Poole IC, Nishimura MI. Moore TV, et al. Among authors: nishimura mi. Cancer Immunol Immunother. 2009 May;58(5):719-28. doi: 10.1007/s00262-008-0594-2. Epub 2008 Oct 3. Cancer Immunol Immunother. 2009. PMID: 18836717 Free PMC article.

9

Characterization of MHC class-I restricted TCRalphabeta+ CD4- CD8- double negative T cells recognizing the gp100 antigen from a melanoma patient after gp100 vaccination.

Voelkl S, Moore TV, Rehli M, Nishimura MI, Mackensen A, Fischer K. Voelkl S, et al. Among authors: nishimura mi. Cancer Immunol Immunother. 2009 May;58(5):709-18. doi: 10.1007/s00262-008-0593-3. Epub 2008 Oct 3. Cancer Immunol Immunother. 2009. PMID: 18836718 Free PMC article.

10

Functional cloning of a gp100-reactive T-cell receptor from vitiligo patient skin.

Klarquist J, Eby JM, Henning SW, Li M, Wainwright DA, Westerhof W, Luiten RM, Nishimura MI, Le Poole IC. Klarquist J, et al. Among authors: nishimura mi. Pigment Cell Melanoma Res. 2016 May;29(3):379-84. doi: 10.1111/pcmr.12458. Epub 2016 Mar 4. Pigment Cell Melanoma Res. 2016. PMID: 26824221 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

132 results

Search Page